Thermo Fisher Scientific to Present at the 2022 Goldman Healthcare CEOs Unscripted Conference

Thermo Fisher Scientific (NYSE: TMO), a leader in serving science, announced that Marc N. Casper, its CEO, will present at the 2022 Goldman Healthcare CEOs Unscripted Conference on January 6, 2022, at 9:00 a.m. EDT.

Rhea-AI Summary

Thermo Fisher Scientific (NYSE: TMO), a leader in serving science, announced that Marc N. Casper, its CEO, will present at the 2022 Goldman Healthcare CEOs Unscripted Conference on January 6, 2022, at 9:00 a.m. EDT. This virtual event will highlight the company's initiatives in the healthcare sector. With an annual revenue of approximately $40 billion, Thermo Fisher supports various industries, including life sciences and diagnostics, through its innovative technologies and services. For more details, visit thermofisher.com.

Argus Session date unavailable

+0.27% session move Open Argus

Details

News Market Reaction – TMO

The recorded move for TMO in the trading session of this news was +0.27%.

Data tracked by StockTitan Argus. Session date unavailable.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

WALTHAM, Mass., Dec. 30, 2021 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper, chairman, president and chief executive officer, will present virtually at the 2022 Goldman Healthcare CEOs Unscripted Conference on Thursday, January 6, 2022, at 9:00 a.m. (EDT). 

You can access the webcast of the presentation via the Investors section of our website, www.thermofisher.com.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team of more than 100,000 colleagues delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.

	Media Contact Information: Ron O'Brien Thermo Fisher Scientific	Investor Contact Information: Rafael Tejada Thermo Fisher Scientific
	Phone: 781-622-1242	Phone: 781-622-1356
	E-mail: ron.obrien@thermofisher.com	E-mail: rafael.tejada@thermofisher.com

 

View original content:https://www.prnewswire.com/news-releases/thermo-fisher-scientific-to-present-at-the-2022-goldman-healthcare-ceos-unscripted-conference-301452032.html

SOURCE Thermo Fisher Scientific

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

When is the Thermo Fisher Scientific presentation at the 2022 Goldman Healthcare CEOs Unscripted Conference?

Marc N. Casper will present on January 6, 2022, at 9:00 a.m. EDT.

Where can I watch the Thermo Fisher Scientific conference presentation?

The presentation can be accessed via the Investors section of Thermo Fisher's website.

What is Thermo Fisher Scientific's annual revenue?

Thermo Fisher Scientific has an annual revenue of approximately $40 billion.

Who is the CEO of Thermo Fisher Scientific?

The CEO of Thermo Fisher Scientific is Marc N. Casper.